Active substance
Results for the substance voclosporin
1 result
About this active substance
Voclosporin is an immunosuppressive medication used for the treatment of active lupus nephritis, a severe complication of systemic lupus erythematosus that affects the kidneys. It is a calcineurin inhibitor that works by suppressing T-cell activity, reducing inflammation, and preventing kidney tissue damage.
Voclosporin is administered orally, usually twice daily, in combination with other immunosuppressive medications and corticosteroids. The dosage is adjusted based on the patient's response and serum drug levels.
Common side effects include high blood pressure, infections, nausea, headaches, and impaired kidney function. In rare cases, severe adverse reactions such as acute kidney failure or allergic reactions may occur.
Patients receiving voclosporin should be regularly monitored for kidney function, blood pressure, and signs of infection. The medication represents an important therapeutic option for patients with lupus nephritis, helping to reduce inflammation and protect kidney function in the long term.
Voclosporin is administered orally, usually twice daily, in combination with other immunosuppressive medications and corticosteroids. The dosage is adjusted based on the patient's response and serum drug levels.
Common side effects include high blood pressure, infections, nausea, headaches, and impaired kidney function. In rare cases, severe adverse reactions such as acute kidney failure or allergic reactions may occur.
Patients receiving voclosporin should be regularly monitored for kidney function, blood pressure, and signs of infection. The medication represents an important therapeutic option for patients with lupus nephritis, helping to reduce inflammation and protect kidney function in the long term.